Have questions for our experts or want more information?
Contact Us Today
Webinar Overview: Discover How High-Density iPSCs Simplify Organoid Differentiation
As the FDA Modernization Act 2.0 accelerates the adoption of predictive, human-relevant New Approach Methodologies (NAMs), research teams are increasingly seeking reliable ways to standardize workflows. A critical part of achieving reproducible NAM results is access to high-quality, consistent cellular materials.
Induced pluripotent stem cells (iPSCs) offer an ideal foundation for NAMs applications because they are scalable, highly expandable, and capable of generating a wide range of differentiated cell types, making them ideal for disease modelling, drug screening, and regenerative medicine. However, researchers often face challenges with genetic drift, functional instability, and user-to-user variability – all of which can compromise data quality and slow development timelines.
In this webinar, experts from Pluristyx will share practical guidance on how standardized iPSC starting materials can help organizations strengthen the reproducibility and efficiency of their NAM-aligned models and assays, particularly organoid systems.
You will learn how:
- Well-characterized, high-density iPSC starting material can streamline your organoid workflows
- Ready-to-differentiate, high-density iPSCs can be thawed and directed into target lineages across adherent and suspension cultures with performance comparable to freshly passaged cells
Webinar Presenters
Raluca Marcu, PhD
Vice President of Science
Pluristyx
Liza Panova, MPharBE
Associate Scientist
Pluristyx